Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pallesen

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Histopathology|February 1, 1991
Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classificationN Hastrup, S Hamilton-Dutoit, E Ralfkiaer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 1989
Follicular involution in HIV lymphadenopathy. A morphometric studyA Porwit, B Böttiger, G Pallesen, et al.
Blood|December 15, 1994
Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomasK Sandvej, S C Peh, B S Andresen, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 1999
Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish populationG Enblad, K Sandvej, C Sundström, et al.
Dermatologica|January 1, 1988
Development of cutaneous pseudolymphoma following ciclosporin therapy of actinic reticuloidK Thestrup-Pedersen, C Zachariae, K Kaltoft, et al.
Lancet (London, England)|June 11, 1983
Experience with the Oxford tumour marker (Ca1) in serous fluidsG Pallesen, F L Jepsen, J Hastrup, et al.
Lancet (London, England)|February 9, 1991
Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseG Pallesen, S J Hamilton-Dutoit, M Rowe, et al.
Leukemia & Lymphoma|November 1, 1994
Expression of human recombination activating genes (RAG-1 and RAG-2) in lymphomaH Knecht, P Brousset, E Bachmann, et al.
International Journal of Cancer|July 15, 1999
Epstein-barr virus in Hodgkin's disease: frequency of a 30-bp deletion in the latent membrane protein (LMP-1) oncogene in South African patientsM F Essop, M Engel, P Close, et al.
Acta Neurologica Scandinavica|February 1, 1993
Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathyM Sommerlund, G Pallesen, A Møller-Larsen, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Histopathology|February 1, 1991
Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classificationN Hastrup, S Hamilton-Dutoit, E Ralfkiaer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 1989
Follicular involution in HIV lymphadenopathy. A morphometric studyA Porwit, B Böttiger, G Pallesen, et al.
Blood|December 15, 1994
Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomasK Sandvej, S C Peh, B S Andresen, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 1999
Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish populationG Enblad, K Sandvej, C Sundström, et al.
Dermatologica|January 1, 1988
Development of cutaneous pseudolymphoma following ciclosporin therapy of actinic reticuloidK Thestrup-Pedersen, C Zachariae, K Kaltoft, et al.
Lancet (London, England)|June 11, 1983
Experience with the Oxford tumour marker (Ca1) in serous fluidsG Pallesen, F L Jepsen, J Hastrup, et al.
Lancet (London, England)|February 9, 1991
Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseG Pallesen, S J Hamilton-Dutoit, M Rowe, et al.
Leukemia & Lymphoma|November 1, 1994
Expression of human recombination activating genes (RAG-1 and RAG-2) in lymphomaH Knecht, P Brousset, E Bachmann, et al.
International Journal of Cancer|July 15, 1999
Epstein-barr virus in Hodgkin's disease: frequency of a 30-bp deletion in the latent membrane protein (LMP-1) oncogene in South African patientsM F Essop, M Engel, P Close, et al.
Acta Neurologica Scandinavica|February 1, 1993
Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathyM Sommerlund, G Pallesen, A Møller-Larsen, et al.
Pageof 11